Trade Summary

2 months ago, Nielsen Kirk G., serving as Dir at Spyglass Pharma, Inc. (SGP), purchased 165,000 shares at $16.00 per share, for a total transaction value of $2,640,000.00. Following this transaction, Nielsen Kirk G. now holds 3,310,619 shares of SGP.

This purchase represents a 5.00% increase in Nielsen Kirk G.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, February 9, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, February 10, 2026, 1 day after the trade was made.

Spyglass Pharma, Inc. operates in the NONE sector, specifically within the NONE industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.